Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Given Average Rating of "Buy" by Analysts

Key Points

• Bayer Aktiengesellschaft (OTCMKTS:BAYRY) has received a consensus rating of "Buy" from five ratings firms, with two analysts issuing a strong buy rating.
• The company reported earnings of $0.35 EPS for the last quarter, surpassing analysts' expectations of $0.25, and had a revenue of $12.42 billion compared to the estimated $10.79 billion.
• Bayer's share price has fluctuated between a one-year low of $4.79 and a high of $8.65, currently trading around $8.00.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) has earned a consensus recommendation of "Buy" from the four research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company.

A number of research firms recently issued reports on BAYRY. Zacks Research downgraded shares of Bayer Aktiengesellschaft from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 1st. Kepler Capital Markets raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research note on Wednesday, June 11th. Wall Street Zen raised shares of Bayer Aktiengesellschaft from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, August 19th. Hsbc Global Res raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, June 11th. Finally, The Goldman Sachs Group raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th.

Bayer Aktiengesellschaft Price Performance

Shares of BAYRY stock traded down $0.09 during mid-day trading on Wednesday, hitting $8.24. The company had a trading volume of 659,540 shares, compared to its average volume of 630,126. Bayer Aktiengesellschaft has a 52-week low of $4.79 and a 52-week high of $8.65. The stock's 50 day moving average price is $7.99 and its 200-day moving average price is $7.08. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.13 and a quick ratio of 0.73. The company has a market capitalization of $32.38 billion, a P/E ratio of -8.49 and a beta of 0.93.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.25 by $0.10. Bayer Aktiengesellschaft had a negative net margin of 7.61% and a positive return on equity of 15.44%. The firm had revenue of $12.42 billion for the quarter, compared to the consensus estimate of $10.79 billion. Equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.